COMMUNIQUÉS West-GlobeNewswire

Kratom Black Friday Sale: 30% off on All Strains | Limited Time Offer
25/11/2024
Celebrate Black Friday with 30% off premium Kratom at Happy Go Leafy! Shop trusted strains and unbeatable quality. Offer valid sitewide—don’t miss out! Miami, Florida , Nov. 25, 2024 (GLOBE NEWSWIRE) -- Get ready for [...]
Alignment Health Plan Expands Access to Care in Arizona through Enhanced Agreement with Arizona Priority Care
25/11/2024
Agreement expansion offers Alignment members access to all Banner Health hospitals and specialists in Arizona PHOENIX and ORANGE, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Alignment Health Plan , an award-winning [...]
Derm-Biome Pharmaceuticals adds Dr. Jerry Tan, internationally renowned expert in acne and acne scarring, to its Scientific Advisory Board
25/11/2024
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver-based biopharmaceutical company developing safe and highly effective topical treatments for inflammatory skin [...]
Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics
25/11/2024
Klothea Bio Secures Funding from Longevitytech.fund as a lead investor to Pioneer Breakthrough Treatments for Metabolic Syndrome and several Aging-Associated Diseases MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Advantage [...]
Immix Biopharma Presents Positive NXC-201 Clinical Data at 66th American Society of Hematology (ASH) Annual Meeting in 16 Relapsed/Refractory AL Amyloidosis Patients
25/11/2024
75% (12/16) complete response rate observed in relapsed/refractory AL Amyloidosis patients with median 4 prior lines of therapy Data will be presented on Monday, December 9, 2024 at 4:00 PM PT LOS ANGELES, Nov. 25, 2024 [...]
Cannara Biotech Inc. annonce ses résultats pour le quatrième trimestre et l’exercice 2024 : Augmentation record des ventes et du flux de trésorerie d'exploitation, renforçant sa position de leader sur le marché canadien du cannabis
25/11/2024
Total des produits records au quatrième trimestre et pour l’exercice 2024 : 23,4 millions de dollars et 82,2 millions de dollars, soit une augmentation de 28 % et 43 % par rapport aux mêmes périodes en 2023. Croissance [...]
Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
25/11/2024
Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023. Robust growth in Q4 over Q3 2024, with total revenues increasing by 20 [...]
Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
25/11/2024
WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial SOUTH JORDAN, Utah, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a [...]
BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™
25/11/2024
LAS VEGAS, Nov. 25, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) received approval today for a human clinical trial of its weight management product, Zeranovia™ . The trial, approved by an [...]
Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24
25/11/2024
November 25, 2024 icometrix’ FDA-cleared quantitative brain solution for neurological conditions including Alzheimer’s and multiple sclerosis is seamlessly integrated into Philips next generation BlueSeal MR scanners, [...]
Cofactor AI Launches Platform to Help Hospitals Fight Tidal Wave of Claims Denials and Announces $4 Million Seed Round
25/11/2024
Cofactor AI is leveling the playing field in the AI arms race between payers and providers CHICAGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Hospitals across the country are facing an ever-increasing onslaught of claims [...]
Sharecare wins 17 Digital Health Awards in Fall 2024
25/11/2024
Company earns Gold for its NCQA-accredited disease management and population health capabilities, evidence-based digital therapeutics, and patient education content ATLANTA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sharecare, [...]
Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution
25/11/2024
New artificial intelligence (AI) capabilities help hospitals and health systems deliver safer and more efficient care PURCHASE, NY, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in [...]
MDxHealth to Participate in Piper Sandler Healthcare Conference
25/11/2024
MDxHealth to Participate in Piper Sandler Healthcare Conference IRVINE, CA – November 25, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, [...]
Spinogenix Appoints American Football Hall of Famer and Health Advocate Steve Young to its Board of Directors
25/11/2024
LOS ANGELES, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of people worldwide, today [...]
QHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024
25/11/2024
Revenue Growth and APA Recognition Drive Momentum for QHSLab in 2024 WEST PALM BEACH, FL, Nov. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ) , an emerging leader in digital healthcare solutions [...]
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
25/11/2024
Five posters to be presented including new long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in FOS and findings around mental health and comorbidity burdens of FOS New pre-clinical data from the [...]
Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
25/11/2024
TN-401 AAV9-based Gene Therapy Designed to Deliver Fully Functional PKP2 Gene with the Aim of Increasing Protein Levels to Address Underlying Disease RIDGE-1 Currently Enrolling at Six Centers; Observational Natural [...]
CytoDyn Appoints Richard Pestell, M.D., Ph.D. as Lead Consultant in Oncology
25/11/2024
VANCOUVER, Washington, Nov. 25, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]

Pages